Compare Cadila Healthcare with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs DR. REDDYS LAB - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE DR. REDDYS LAB CADILA HEALTHCARE/
DR. REDDYS LAB
 
P/E (TTM) x 18.5 17.7 104.7% View Chart
P/BV x 2.5 3.4 73.2% View Chart
Dividend Yield % 1.4 0.7 199.5%  

Financials

 CADILA HEALTHCARE   DR. REDDYS LAB
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-19
DR. REDDYS LAB
Mar-19
CADILA HEALTHCARE/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs4322,875 15.0%   
Low Rs3061,888 16.2%   
Sales per share (Unadj.) Rs128.6930.2 13.8%  
Earnings per share (Unadj.) Rs18.5117.4 15.8%  
Cash flow per share (Unadj.) Rs24.4185.8 13.1%  
Dividends per share (Unadj.) Rs3.5020.00 17.5%  
Dividend yield (eoy) %0.90.8 112.8%  
Book value per share (Unadj.) Rs101.5844.4 12.0%  
Shares outstanding (eoy) m1,023.74166.07 616.5%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x2.92.6 112.2%   
Avg P/E ratio x19.920.3 98.2%  
P/CF ratio (eoy) x15.112.8 118.1%  
Price / Book Value ratio x3.62.8 129.1%  
Dividend payout %18.917.0 110.8%   
Avg Mkt Cap Rs m378,170395,496 95.6%   
No. of employees `00012.422.0 56.6%   
Total wages/salary Rs m21,24133,562 63.3%   
Avg. sales/employee Rs Th10,585.07,032.8 150.5%   
Avg. wages/employee Rs Th1,707.81,527.9 111.8%   
Avg. net profit/employee Rs Th1,526.5887.7 172.0%   
INCOME DATA
Net Sales Rs m131,656154,482 85.2%  
Other income Rs m2,0113,375 59.6%   
Total revenues Rs m133,667157,857 84.7%   
Gross profit Rs m29,73131,782 93.5%  
Depreciation Rs m5,98611,348 52.7%   
Interest Rs m1,935889 217.7%   
Profit before tax Rs m23,82122,920 103.9%   
Minority Interest Rs m4690-   
Prior Period Items Rs m0438 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,3033,858 137.5%   
Profit after tax Rs m18,98719,500 97.4%  
Gross profit margin %22.620.6 109.8%  
Effective tax rate %22.316.8 132.3%   
Net profit margin %14.412.6 114.3%  
BALANCE SHEET DATA
Current assets Rs m84,981111,101 76.5%   
Current liabilities Rs m73,42558,973 124.5%   
Net working cap to sales %8.833.7 26.0%  
Current ratio x1.21.9 61.4%  
Inventory Days Days7579 93.9%  
Debtors Days Days11094 116.3%  
Net fixed assets Rs m133,493101,245 131.9%   
Share capital Rs m1,024830 123.4%   
"Free" reserves Rs m102,839139,406 73.8%   
Net worth Rs m103,863140,236 74.1%   
Long term debt Rs m39,49722,000 179.5%   
Total assets Rs m234,831224,656 104.5%  
Interest coverage x13.326.8 49.7%   
Debt to equity ratio x0.40.2 242.4%  
Sales to assets ratio x0.60.7 81.5%   
Return on assets %8.99.1 98.2%  
Return on equity %18.313.9 131.5%  
Return on capital %18.314.9 122.4%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m48,40488,673 54.6%   
Fx outflow Rs m11,59319,104 60.7%   
Net fx Rs m36,81169,569 52.9%   
CASH FLOW
From Operations Rs m28,82328,704 100.4%  
From Investments Rs m-57,387-7,727 742.7%  
From Financial Activity Rs m18,846-21,326 -88.4%  
Net Cashflow Rs m-7,105-314 2,262.7%  

Share Holding

Indian Promoters % 74.8 25.5 293.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 5.4 153.7%  
FIIs % 5.9 35.3 16.7%  
ADR/GDR % 0.0 18.5 -  
Free float % 11.0 15.3 71.9%  
Shareholders   44,069 75,885 58.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   STRIDES PHARMA SCIENCE  AJANTA PHARMA  ALEMBIC LTD  ALEMBIC PHARMA  WOCKHARDT  

Compare CADILA HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Witness Selling; Sensex Down 235 Points(12:30 pm)

Share markets in India are presently trading on a negative note. Sectoral indices are trading on a mixed note with stocks in the IT sector.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (2QFY20); Net Profit Down 79.3% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, CADILA HEALTHCARE has posted a net profit of Rs 829 m (down 79.3% YoY). Sales on the other hand came in at Rs 34 bn (up 13.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 28.9% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CADILA HEALTHCARE has posted a net profit of Rs 3 bn (down 28.9% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 21.0% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 21.0% YoY). Sales on the other hand came in at Rs 37 bn (up 14.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

More Views on News

Most Popular

The Smartest Stock to Buy for 2020(Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

The One Trade I'm Most Bullish on Now

Nov 12, 2019

A highly specific trade to potentially triple your money in just three months. You won't find this information anywhere else!

How the Modi Government is Helping My Top 7 Stocks(The 5 Minute Wrapup)

Nov 14, 2019

Recent reforms by the Modi government can give a big boost on your stocks, provided you buy the right ones.

I Think Nestle, HUL, and Asian Paints Could Give Low Returns(Profit Hunter)

Nov 15, 2019

If you think high quality stocks will continue their dream run forever, then you must read this now.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Nov 22, 2019 03:37 PM

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 5-YR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS